Biologics & Biosimilars Pipeline- Phase XSMonoclonal Antibodies Shaping the Dermatology Space!Biologics are the future of innovative therapeutics in dermatology. Various biologics such as monoclonal antibodies, recombinant human…Jan 29, 2020Jan 29, 2020
DCVCReimagining biologics: AbCellera and Novartis partner to find new disease treatmentsThe companies are joining forces to find therapeutic antibodies for up to 10 target diseases.Feb 14, 2019Feb 14, 2019
Ryan BusheyReasonable Growth Projected for Vasculitis Treatment Spaceby: Ryan BusheyFeb 15, 2016Feb 15, 2016
Rahul DevinPatent Attorney and Blockchain Technology Business Lawyer - Rahul DevBioSpectrum Asia — Compulsory License of Bayer’s NexavarJan 20, 2016Jan 20, 2016
Rahul DevBioSpectrum — Regulatory Challenges For APAC Businesses — Biotech in Asia PacificJan 10, 2016Jan 10, 2016
